Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |